HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
6,830.00
+30.00 (0.44%)
Nov 17, 2026, 3:30 PM KST
HLB Pharmaceutical Market Cap
HLB Pharmaceutical has a market cap or net worth of 224.02 billion as of November 16, 2026. It is the 21,379th most valuable company in the world and the 712th biggest in South Korea. Its market cap has decreased by 4.01% in one year.
Market Cap
224.02B
Enterprise Value
168.85B
Revenue
253.85B
Global Rank
Country Rank
#712 South Korea
PE Ratio
68.06
ChartMarket Cap Chart
Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 224.02B, an increase of 165.80%. That is a compound annual growth rate of 9.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 224.02B | -0.54% |
| Dec 30, 2025 | 225.24B | -33.44% |
| Dec 30, 2024 | 338.42B | 58.45% |
| Dec 28, 2023 | 213.58B | 43.49% |
| Dec 29, 2022 | 148.85B | -21.48% |
| Dec 30, 2021 | 189.57B | -21.05% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| JW Holdings | 253.58B |
| Samjin Pharmaceuticals | 245.16B |
| Humedix | 233.75B |
| Korea United Pharm | 220.35B |
| Whan In Pharm | 198.33B |
| Huons | 179.90B |
| Suheung | 179.07B |
| REYON Pharmaceutical | 174.42B |